Enzo Biochem CEO Elazar Rabbani's 2020 pay slips 1% to $1.5M
Enzo Biochem reports 2020 executive compensation
By ExecPay News
Published: November 27, 2020
Enzo Biochem reported fiscal year 2020 executive compensation information on November 27, 2020.
In 2020, five executives at Enzo Biochem received on average a compensation package of $778K, a 15% decrease compared to previous year.
Elazar Rabbani, Chief Executive Officer, received $1.5M in total, which decreased by 1% compared to 2019. 41% of Rabbani's compensation, or $611K, was in salary. Rabbani also received $500K in non-equity incentive plan, $112K in option awards, $70K in stock awards, as well as $195K in other compensation.
Barry W. Weiner, President and Treasurer, received a compensation package of $1.3M, which decreased by 1% compared to previous year. 43% of the compensation package, or $542K, was in salary.
Dieter Schapfel, Chief Medical Director,, earned $482K in 2020, a 1% decrease compared to previous year.
Enzo Clinical Labs Kara Cannon, Chief Commercial Officer, received $371K in 2020, which decreases by 2% compared to 2019.
David Bench, Chief Financial Officer, earned $296K in 2020.
Enzo Biochem's fiscal year ends on July 31.